Skip to content

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07107139
Enrollment
50
Registered
2025-08-06
Start date
2026-05-11
Completion date
2027-05-01
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smokeless Tobacco

Brief summary

This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.

Interventions

OTHERCopenhagen group

Participants use product for up to 30 minutes

OTHERSnus group

Participants use product for up to 30 minutes

Sponsors

Roswell Park Cancer Institute
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 21 years of age * Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming) * Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year * Open to trying a non-combusted oral tobacco product * Have the ability to read, write, and communicate in English * Have successfully completed our preliminary Auction study I-4008824 with a bid for Copenhagen and/or General Snus \> $0 * Willing to abstain smoking 8-10 hours prior to each laboratory session and complete breath CO test for verification (\<8ppm) * Female participants must be amenable to taking a pregnancy test (urine) prior to beginning study procedures. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.

Exclusion criteria

* Age ≥ 21 years of age * Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming) * Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year * Open to trying a non-combusted oral tobacco product * Have the ability to read, write, and communicate in English * Have successfully completed our preliminary Auction study I-4008824 with a bid for Copenhagen and/or General Snus \> $0 * Willing to abstain smoking 8-10 hours prior to each laboratory session and complete breath CO test for verification (\<8ppm) . * Female participants must be amenable to taking a pregnancy test (urine) prior to beginning study procedures. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.

Design outcomes

Primary

MeasureTime frameDescription
Change in sensory responseBefore viewing study ads and immediatley after viewingassessed with a 0-100 visual analog scale - anchored by word descriptors at each end.

Secondary

MeasureTime frameDescription
Change in nicotine boostWill be collected after 5, 15 and 30 minutes of product use.Will be measured after use of products with gas chromatography-mass spectrometry

Countries

United States

Contacts

CONTACTASK RPCI
askrpci@roswellpark.org1-877-275-7724

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026